Growth Funding Opportunity Recent financing rounds and a private placement indicate readiness to scale manufacturing and sales. With a lean team and mid range revenue, there is an opportunity to engage growth capital or strategic investors to accelerate production, expand sales channels, and enter new markets including international distribution and clinical validation partnerships.

Core Customers Targeting Primary customers are dermatologists, pathologists, and researchers who rely on real time tissue imaging. Sales strategies should target clinics and academic centers, emphasizing workflow efficiency, speed, diagnostic clarity, and integration with existing clinical workflows.

Product Upsell Strategy Caliber's VivaScope imaging systems present opportunities to upsell through system upgrades, service contracts, training, and consumables. There is potential to cross-sell Ex Vivo and In Vivo offerings, software add ons, and data analytics to improve utilization and outcomes.

Competitive Market Trends The market favors real time digital pathology tools, and Caliber differentiates through close clinical collaboration, high resolution imaging, and faster decision making. Growing interest in rapid pathology workflows and remote or telepathology can be leveraged to expand adoption in dermatology and research settings.

Operational Partnerships With a small team and existing Salesforce based pipeline management, Caliber could accelerate growth by expanding distribution partners and academic collaborations, strengthening marketing and sales enablement, and pursuing co development or OEM partnerships to broaden reach.